Pectolinarigenin regulates the tumor-associated proteins in AGS-xenograft BALB/c nude mice.

Our findings suggested that PEC therapy may inhibit tumor development in gastric cancer (GC), and proteomic research gives fundamental information about proteins that may have great promise as new therapeutic targets in GC.